Ketogenic diet and ketamine infusion treatment to target chronic persistent eating disorder psychopathology in anorexia nervosa: a pilot study
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Purpose: Anorexia nervosa (AN) is a severe psychiatric disorder, and shape and weight concerns are often chronic despite weight normalization. No specific treatments exist for those preoccupations that interfere with recovery and trigger relapse. A case study using a ketogenic diet followed by ketamine infusions led to sustained remission in one patient with chronic AN. Here we conducted an open-label trial to test whether this response could be replicated. Methods: Five adults weight recovered from AN but with persistent eating disorder thoughts and behaviors adopted a therapeutic ketogenic diet (TKD) aimed at maintaining weight. After sustaining nutritional ketosis, participants received six ketamine infusions and were followed over 6 months. Results: All participants completed the study protocol without significant adverse effects. Two participants maintained TKD for 8 weeks prior to ketamine infusions due to good behavioral response and remained on TKD. Three participants received TKD for 4 weeks prior to and during ketamine, then tapered off after the final infusion. The group showed significant improvements on the Clinical Impairment Assessment ( p = 0.008), Eating Disorder Examination Questionnaire (EDEQ) Global score ( p = 0.006), EDEQ-Eating Concerns ( p = 0.005), EDEQ-Shape Concerns ( p = 0.016), EDEQ-Weight Concerns ( p = 0.032), Eating Disorders Recovery Questionnaire (EDRQ) Acceptance of Self and Body (0.027) and EDRQ-Social and Emotional Connection ( p = 0.001). Weight remained stable, except for one participant who relapsed 4 months after treatment and off TKD. Conclusion: This novel treatment appears to be safe and effective for adults with chronic AN-related psychopathology. The results from this open trial support that there are specific neurobiological underpinnings of AN that can be normalized using TKD and ketamine. Level of evidence: Level IV, multiple time series with intervention
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“importantly, these were found to last for up to six months [121]”
From Ketamine in neuropsychiatric disorders: an update (2024) · cites this paper as [121]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Initiative, A. N. G., Watson, H. J., Eating Disorders Working Group of the Psychiatric Genomics Consortium, Yilmaz, Z., Thornton, L. M., Hübel, C., Coleman, J. R. I., Gaspar, H. A., Bryois, J., Hinney, A., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0439-2 · Cited by 1,109
Kokkinou, M., Ashok, A. H., & Howes, O. D. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.190 · Cited by 247 · cited 2×
“Ketamine, on the other hand, leads to dopamine release [7], which may reset a circuitry that has adapted to food restriction by low dopamine release but elevated receptor sensitivity and high anxiety.”
Ketogenic diet as a metabolic therapy for mood disorders: Evidence and developments
Brietzke, E., Mansur, R. B., Subramaniapillai, M., Balanzá-Martínez, V., Vinberg, M., González-Pinto, A., Rosenblat, J. D., Ho, R., & McIntyre, R. S. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.07.020 · Cited by 173 · cited 2×
“Ketogenic diet has been shown effective in neurological conditions and shows promise in mood disorders, and could similarly help normalize brain circuit function and behaviors in AN [8].”
Cheng, B., Yang, X., An, L., Gao, B., Liu, X., & Liu, S. (2009) · Brain Research · doi:10.1016/j.brainres.2009.06.060 · Cited by 113
Frank, G., Shott, M. E., Stoddard, J., Swindle, S., & Pryor, T. L. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2021.1580 · Cited by 95
Self-citationSevere and enduring anorexia nervosa (SE-AN): in search of a new paradigm
Touyz, S., & Hay, P. (2015) · Journal of Eating Disorders · doi:10.1186/s40337-015-0065-z · Cited by 90 · cited 1×
“The mortality rate of AN is among the highest among the psychiatric disorders, but there is no FDA-approved medication for the treatment of AN, and the effectiveness of psychotherapeutic interventions especially for severe and enduring AN is limited [1].”
Treatment of compulsive behaviour in eating disorders with intermittent ketamine infusions
Mills, I. (1998) · QJM · doi:10.1093/qjmed/91.7.493 · Cited by 87 · cited 1×
“In another ABA paradigm, the single injection of the N-methyl-d-aspartate (NMDA) receptor antagonist ketamine was protective for survival [3], and infusion of ketamine in adult women with chronic AN led to improvement in obsessional symptoms [4].”
Metabolism and epilepsy: Ketogenic diets as a homeostatic link
Masino, S. A., & Rho, J. M. (2019) · Brain Research · doi:10.1016/j.brainres.2018.05.049 · Cited by 70
Remission from Chronic Anorexia Nervosa With Ketogenic Diet and Ketamine: Case Report
Scolnick, B., Zupec-Kania, B., Calabrese, L., Aoki, C., & Hildebrandt, T. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00763 · Cited by 68
Self-citationActivity-based anorexia animal model: a review of the main neurobiological findings
Spadini, S., Ferro, M., Lamanna, J., & Malgaroli, A. (2021) · Journal of Eating Disorders · doi:10.1186/s40337-021-00481-x · Cited by 61
Cited by
Ketamine in neuropsychiatric disorders: an update
Johnston, J. N., Kadriu, B., Kraus, C., Henter, I. D., & Zarate, C. A. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-023-01632-1 · Cited by 108
“Signi fi cant improvements were found across multiple measures on the Eating Disorder Examination Questionnaire and Clinical Impairment Assessment; importantly, these were found to last for up to six months [121].”
BackgroundUltra-Processed Foods and Mental Health: Where Do Eating Disorders Fit into the Puzzle?
Wiss, D. A., & LaFata, E. M. (2024) · Nutrients · doi:10.3390/nu16121955 · Cited by 55
Mentzelou, M., Dakanalis, A., Vasios, G. K., Gialeli, M., Papadopoulou, S. Κ., & Giaginis, C. (2023) · Nutrients · doi:10.3390/nu15102270 · Cited by 50
“…on the Clinical Impairment Assessment, Eating Disorder Examination Questionnaire (EDEQ) Global Rating, EDEQ-Eating Concerns, EDEQ-Weight Concerns, EDEQ-Shape Concerns, Eating Disorders Recovery Questionnaire (EDRQ) Acceptance of Self and Body, and EDRQ-Social and Emotional Connection [85].”
BackgroundMethodInfluentialBrewerton, T. D. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1149433 · Cited by 46
Complete remission of depression and anxiety using a ketogenic diet: case series
Calabrese, L. V., Frase, R., & Ghaloo, M. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1396685 · Cited by 47
Self-citation
Metadata
- Authors
- Calabrese, L., Scolnick, B., Zupec-Kania, B., Beckwith, C., Costello, K., & Frank, G. K. W.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- University of California San Diego (US)
- Corresponding author
- Calabrese, Lori
- Venue
- Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity
- Published
- 2022-08-23
- Volume
- 27
- Issue
- 8
- Pages
- 3751-3757
- ISSN
- 1124-4909 (ISSN-L)
- 1590-1262
- PMC
- PMC9803738
- OpenAlex
- W4292707670
- Cited by
- 56
- References
- 10
- Citations by year
- 2026: 10 · 2025: 20 · 2024: 16 · 2023: 9 · 2022: 1
- FWCI
- 10.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- Homeostasis Therapeutics
- Topics
- Social Sciences › Psychology › Clinical Psychology › Eating Disorders and Behaviors
- Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
- Health Sciences › Nursing › Nutrition and Dietetics › Nutrition, Health and Food Behavior
- Keywords
- anorexia nervosa, ketamine infusion, weight concern, shape concern, eating concerns, weight maintenance, relapse, eating disorder recovery, nutritional ketosis
- MeSH terms
- Adult, Anorexia Nervosa, Feeding and Eating Disorders, Humans, Ketamine, Pilot Projects, Diet, Ketogenic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ketogenic diet and ketamine infusion treatment to target chronic persistent eating disorder psychopathology in anorexia nervosa: a pilot study. https://app.cochat.ai/papers/10.1007/s40519-022-01455-x
- The paper
- Calabrese, L., Scolnick, B., Zupec-Kania, B., Beckwith, C., Costello, K., & Frank, G. K. W. (2022). Ketogenic diet and ketamine infusion treatment to target chronic persistent eating disorder psychopathology in anorexia nervosa: a pilot study. Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity. https://doi.org/10.1007/s40519-022-01455-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
